We are live on ! Find out more
HAG

HighPoint Advisor Group Portfolio holdings

AUM $2.84B
1-Year Est. Return 31.94%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$821M
AUM Growth
+$268M
Cap. Flow
+$155M
Cap. Flow %
18.9%
Top 10 Hldgs %
32.96%
Holding
536
New
147
Increased
262
Reduced
76
Closed
40
Avg Time Held
8.4 quarters
Top 10 Avg Time Held
5.7 quarters
Top 20 Avg Time Held
11.3 quarters

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$14.1M
2
CME icon
CME Group
CME
+$10.3M
3
TSLA icon
Tesla
TSLA
+$8.97M
4
ABBV icon
AbbVie
ABBV
+$8.36M
5
ABT icon
Abbott
ABT
+$8.2M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$12.4M
2
FISV icon
Fiserv Inc
FISV
+$6.48M
3
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$2.65M
4
MRNA icon
Moderna
MRNA
+$1.34M
5
TLSA icon
Tiziana Life Sciences
TLSA
+$1.34M

Sector Composition

Rank Sector Weight
1 Technology 26.32%
2 Healthcare 14.7%
3 Consumer Discretionary 13.39%
4 Financials 12.62%
5 Communication Services 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EW icon
176
Edwards Lifesciences
EW
$49.1B
$769K 0.09%
8,968
+703
+9% +$58.3K
2017 Q1
15 quarters
ADI icon
177
Analog Devices
ADI
$197B
$762K 0.09%
+4,986
New +$661K
2020 Q4
0 quarters
APTV icon
178
Aptiv
APTV
$9.09B
$758K 0.09%
5,113
+355
+7% +$39.4K
2019 Q2
6 quarters
FTNT icon
179
Fortinet
FTNT
$143B
$758K 0.09%
+23,685
New +$599K
2020 Q4
0 quarters
ATVI
180
DELISTED
Activision Blizzard
ATVI
$756K 0.09%
7,361
+4,804
+188% +$390K
2020 Q3
1 quarter
BTAI icon
181
DELISTED
BioXcel Therapeutics
BTAI
$737K 0.09%
771
-64
-8% -$49.9K
2020 Q1
3 quarters
CSIQ icon
182
Canadian Solar
CSIQ
$773M
$731K 0.09%
12,030
-291
-2% -$11.9K
2020 Q3
1 quarter
GSAT icon
183
Globalstar
GSAT
$10.9B
$728K 0.09%
+23,333
New +$113K
2020 Q4
0 quarters
USB icon
184
US Bancorp
USB
$88.9B
$728K 0.09%
15,292
+2,948
+24% +$125K
2016 Q1
19 quarters
ETN icon
185
Eaton
ETN
$167B
$723K 0.09%
6,035
+2,011
+50% +$227K
2016 Q2
18 quarters
ACAD icon
186
Acadia Pharmaceuticals
ACAD
$3.41B
$716K 0.09%
14,189
+5,018
+55% +$249K
2020 Q3
1 quarter
PPG icon
187
PPG Industries
PPG
$23.1B
$714K 0.09%
+5,197
New +$724K
2020 Q4
0 quarters
AZN icon
188
AstraZeneca
AZN
$247B
$711K 0.09%
7,052
+2,012
+40% +$213K
2015 Q4
20 quarters
X icon
189
DELISTED
US Steel
X
$702K 0.09%
42,683
-799
-2% -$9.93K
2019 Q1
7 quarters
C icon
190
Citigroup
C
$217B
$698K 0.09%
11,058
+1,255
+13% +$63.8K
2016 Q1
19 quarters
KMI icon
191
Kinder Morgan
KMI
$72.3B
$691K 0.08%
47,402
+3,148
+7% +$42.1K
2016 Q1
19 quarters
LH icon
192
Labcorp
LH
$25.3B
$689K 0.08%
3,537
+156
+5% +$26.9K
2020 Q1
3 quarters
D icon
193
Dominion Energy
D
$54.2B
$686K 0.08%
9,377
+23
+0.2% +$1.83K
2016 Q1
19 quarters
SAIC icon
194
Saic
SAIC
$5.64B
$679K 0.08%
6,925
– –
2019 Q4
4 quarters
LITE icon
195
Lumentum
LITE
$99.9B
$678K 0.08%
7,791
+3,213
+70% +$277K
2020 Q1
3 quarters
PBA icon
196
Pembina Pipeline
PBA
$27.5B
$661K 0.08%
+23,810
New +$560K
2020 Q4
0 quarters
CMI icon
197
Cummins
CMI
$72.1B
$656K 0.08%
2,678
+1,051
+65% +$236K
2016 Q1
19 quarters
MAXN icon
198
DELISTED
Maxeon Solar Technologies
MAXN
$656K 0.08%
+119
New +$263K
2020 Q4
0 quarters
INSG icon
199
Inseego
INSG
$80.5M
$655K 0.08%
3,335
-865
-21% -$95.6K
2019 Q2
6 quarters
ELV icon
200
Elevance Health
ELV
$89.5B
$653K 0.08%
2,186
+585
+37% +$180K
2019 Q2
6 quarters
6 7
8
9 10

Similar funds

FMC
First Merchants Corp Muncie, Indiana $2.84B AUM 15.58% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.84B AUM
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return
BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $2.83B AUM 14.03% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
WGI
Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return
RL
Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

HighPoint Advisor Group's Q4 2020 Portfolio in Review

As of Q4 2020, HighPoint Advisor Group held 536 positions worth $821M, up 49% from $553M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

HighPoint Advisor Group deployed $155M of net new capital in Q4 2020, opening 147 new positions and adding to 262 existing holdings. Its largest new stake was CME Group: 60,752 shares worth $11.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Clorox, an estimated $12.4M trimmed.

  • HighPoint Advisor Group's largest Q4 2020 buy was CME Group: 60,752 shares worth $11.7M.
  • HighPoint Advisor Group added most to Apple in Q4 2020, an estimated $14.1M increase.
  • HighPoint Advisor Group's biggest Q4 2020 reduction was Clorox, cutting an estimated $12.4M.
  • HighPoint Advisor Group fully exited Tiziana Life Sciences in Q4 2020, selling an estimated $1.34M.
  • HighPoint Advisor Group's ten largest holdings make up 33% of its $821M portfolio in Q4 2020.
  • HighPoint Advisor Group opened 147 new positions and closed 40 in Q4 2020.
  • HighPoint Advisor Group's portfolio value rose 49% quarter-over-quarter to $821M.

Based on HighPoint Advisor Group's 13F filing for Q4 2020, filed 10 Feb 2021.